S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

PYXS Pyxis Oncology Inc

1.17

0.00 (0.00%)

Pre Market

Last Updated: 03:05:50

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Pyxis Oncology (NASDAQ:PYXS)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Pyxis Oncology Charts.

Pyxis Oncology (NASDAQ:PYXS)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Pyxis Oncology Charts.

Pyxis Oncology Inc News

Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference
Monday 3 March 2025 (3 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 26 February 2025 (1 week ago) • Edgar (US Regulatory)

Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer
Wednesday 26 February 2025 (1 week ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 4 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 4 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial
Tuesday 4 February 2025 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 19 December 2024 (3 months ago) • Edgar (US Regulatory)

Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201
Thursday 19 December 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 27 November 2024 (3 months ago) • Edgar (US Regulatory)

More Pyxis Oncology Inc News Articles

Accredited Solutions (PK)

NioCorp Developments

Bell Buckle (PK)

Good Vibrations Shoes (PK)

Code Green Apparel (PK)

Asia Broadband (PK)

RespireRx Pharmaceuticals (CE)

Bioelectronics (PK)

Impact Fusion (PK)

Voip Pal Com (QB)

AMC Entertainment

Cann American (CE)

Adia Nutrition (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions